Choledrene

product on market Capsule Hi-Tech Pharmaceuticals 🟢 Safety: 90/100
Brand: Hi-Tech Pharmaceuticals
🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 60% of ingredients have research evidence
A Label Compliance Grade

Product Label

Label for Choledrene
📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

3 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
60% Evidence Coverage

Supplement Facts — Evidence Check

Vitamin C
8.3 mg (13% DV)
0.55 mg (27% DV)
✅ Within RDA (0.4× RDA of 1.3 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 0.55mg UL 100mg
333 mcg (83% DV)
✅ Within RDA (0.8× RDA of 0.4 mg) 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 0.333mg UL 1.0mg
25 mg (6% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 25mg
Proprietary blend
600 mg

Other Ingredients

Gelatin Stearic Acid FD&C Red #40 FD&C Blue #1

Label Claims — Verification

❓ All Other
❓ Structure/Function
All Other (99% of products) Structure/Function (83% of products) Nutrient (54% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use: Take 3 capsules daily. Do not exceed 3 capsules per day.

Additional Information

- Cardiovascular Health Support Complex - Phytostatin(TM) Formula with Monascus Purpureus - Proprietary Antioxidant Blend with Liver Support Co-factors

HI-TECH PHARMACEUTICALS HTP

CARDIOVASCULAR and CHOLESTEROL SUPPORT

600 mg

Product Details

UPC / SKU 8 57084 00036 1
DSLD Entry Date 2012-06-25
Product Type Other Combinations
Form Capsule
Brand Hi-Tech Pharmaceuticals
DSLD ID 10235
Data Updated 2026-04-11

Research Evidence

371 Research Sources
54 Avg Quality Score
148 Meta Analysis
82 Systematic Review
71 Rct
62 Clinical Trial
2 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Other
1 Openfda Safety
A Vitamin C supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015
PubMed DOI Cochrane
A Vitamin C supplementation for the primary prevention of cardiovascular disease
Systematic Review The Cochrane database of systematic reviews 2017
PubMed DOI Cochrane
A Vitamin C for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2013
PubMed DOI Cochrane
A Vitamin C for preventing and treating pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013
PubMed DOI Cochrane
A Vitamin E supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015
PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Meta Analysis The Cochrane database of systematic reviews 2020
PubMed DOI Cochrane
A Vitamin C supplementation for prevention and treatment of pneumonia
Systematic Review The Cochrane database of systematic reviews 2021
PubMed DOI Cochrane
A Nutritional interventions for preventing and treating pressure ulcers
Meta Analysis The Cochrane database of systematic reviews 2024
PubMed DOI
A Does Vitamin C Supplementation Provide a Protective Effect in Periodontal Health? A Systematic Review and Meta-Analysis
Meta Analysis International journal of molecular sciences 2024
PubMed DOI
A Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study
Meta Analysis BMC medicine 2021
PubMed DOI
View all evidence for Vitamin C →

Compare Similar Products

Vitamin C Ester Ascorbyl Palmitate
Vitamin C Ester Ascorbyl Palmitate OL Olympian Labs 100
Vitamin C 1000 mg
Vitamin C 1000 mg PurHEALTH 100
Ultra C Buffered New Sun 100
Black Elderbarry with Liposomal Vitamin C & Zinc
Black Elderbarry with Liposomal Vitamin C & Zinc SunVita Health 100
Natural Vitamin C Herbadiet 100
View all Vitamin C products →
Vitamin C research & evidence Best Vitamin C rankings All Vitamin C products More from Hi-Tech Pharmaceuticals View on NIH DSLD →